1. Home
  2. INLX vs ANTX Comparison

INLX vs ANTX Comparison

Compare INLX & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INLX
  • ANTX
  • Stock Information
  • Founded
  • INLX 1996
  • ANTX 2017
  • Country
  • INLX United States
  • ANTX United States
  • Employees
  • INLX N/A
  • ANTX N/A
  • Industry
  • INLX EDP Services
  • ANTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • INLX Technology
  • ANTX Health Care
  • Exchange
  • INLX Nasdaq
  • ANTX Nasdaq
  • Market Cap
  • INLX 40.8M
  • ANTX 34.4M
  • IPO Year
  • INLX N/A
  • ANTX 2022
  • Fundamental
  • Price
  • INLX $11.75
  • ANTX $1.23
  • Analyst Decision
  • INLX
  • ANTX Buy
  • Analyst Count
  • INLX 0
  • ANTX 2
  • Target Price
  • INLX N/A
  • ANTX $2.00
  • AVG Volume (30 Days)
  • INLX 6.8K
  • ANTX 59.2K
  • Earning Date
  • INLX 11-12-2025
  • ANTX 11-12-2025
  • Dividend Yield
  • INLX N/A
  • ANTX N/A
  • EPS Growth
  • INLX N/A
  • ANTX N/A
  • EPS
  • INLX N/A
  • ANTX N/A
  • Revenue
  • INLX $17,127,854.00
  • ANTX N/A
  • Revenue This Year
  • INLX N/A
  • ANTX N/A
  • Revenue Next Year
  • INLX $14.19
  • ANTX N/A
  • P/E Ratio
  • INLX N/A
  • ANTX N/A
  • Revenue Growth
  • INLX N/A
  • ANTX N/A
  • 52 Week Low
  • INLX $8.74
  • ANTX $0.98
  • 52 Week High
  • INLX $16.50
  • ANTX $1.68
  • Technical
  • Relative Strength Index (RSI)
  • INLX 55.67
  • ANTX 48.81
  • Support Level
  • INLX $10.60
  • ANTX $1.18
  • Resistance Level
  • INLX $11.10
  • ANTX $1.30
  • Average True Range (ATR)
  • INLX 0.17
  • ANTX 0.07
  • MACD
  • INLX -0.01
  • ANTX -0.01
  • Stochastic Oscillator
  • INLX 67.25
  • ANTX 29.91

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

Share on Social Networks: